Life Sciences Investors Sound the Alarm Over Drug Price

September 20, 2021

Washington, D.C., Sept. 16, 2021 (GLOBE NEWSWIRE) — Yesterday, a group of early-stage life science investors and biotech CEOs joined together with a prominent patient advocate to speak out against H.R.3, known as the Lower Drug Costs Now Act. The panel was hosted by life sciences venture capital coalition Incubate and held at the National Press Club.

Read the source article at Send Press Releases with GlobeNewswire
2021-09-16 20:35:00

Share This Story!